We are building the missing diagnostic layer in obesity and nutrition medicine. Today, treatment decisions are still guided mainly by body weight, questionnaires, and trial and error. We measure ingestive behaviour directly, with medical-grade sensors, signal processing, and digital biomarkers that capture how people actually consume food and drinks. This creates a new class of actionable data for diagnosis, treatment selection, and therapy monitoring. Our platform can help identify who responds to which intervention, track therapeutic success earlier, and support more precise care in metabolic medicine. In short, we turn behaviour into measurable physiology for precision health.
No news
02.03.2026
Submission of BRIDGE PoC grant
12.01.2024
Expansion of collaborations with research institutes in Middle East Asia.
18.12.2023
Presented our project to the VC Company Wingman
15.12.2023
Garnered interest from major pharmaceutical firms.
31.10.2023
Secured 50 ready-to-buy customers.
No Jobs
No videos and documents
No Awards
Website:
www.obios.ch
Headquarter:
Zurich
Technology:
Sectors: